Table 4.

Antioxidant screening results of the synthesized compounds (T₁–T₂₀)

Compounds	% inhibition				IC50 (µg/ml)
	25 (µg/ml)	50 (µg/ml)	75 (µg/ml)	100 (µg/ml)
T1	25.45	49.65	69.67	94.78	46.83
T2	45.67	56.98	70.16	84.21	34.83
T3	43.56	60.12	75.67	88.98	34.38
T4	38.45	58.34	88.61	98.89	37.50
T5	42.34	55.67	68.98	78.12	39.13
T6	31.67	53.67	77.78	92.67	45.66
T7	46.75	52.56	60.56	70.41	38.54
T8	43.91	58.67	67.54	82.57	36.12
T9	40.56	60.67	83.61	92.16	35.42
T10	45.56	51.56	57.57	62.67	43.57
T11	35.78	52.89	70.89	89.9	45.36
T12	44.45	51.45	68.56	70.61	39.56
T13	43.46	57.67	73.76	89.56	36.40
T14	37.56	60.68	85.79	95.61	37.52
T15	38.56	50.64	62.16	80.56	47.99
T16	43.65	51.45	67.26	81.76	41.30
T17	48.75	62.57	78.16	84.61	24.90
T18	39.59	68.57	80.13	95.89	33.34
T19	38.45	58.34	80.61	96.89	38.99
T20	33.45	53.67	70.46	92.67	46.34
Ascorbic acid	38.67	63.68	84.78	94.45	35.44

Italics signifies the most active compound in comparison to the standard compound